Covaxin-maker Bharat Biotech MD D Krishna Ella and Suchitra Ella conferred “Padma Bhushan”
New Delhi [India]: Bharat Biotech Managing Director (MD) D Krishna Ella and Joint MD Suchitra Ella received the Padma Bhushan award from President Ram Nath
New Delhi [India]: Bharat Biotech Managing Director (MD) D Krishna Ella and Joint MD Suchitra Ella received the Padma Bhushan award from President Ram Nath
New Delhi [India]: Experts said that those children who are getting anti-COVID vaccines should not take paracetamol before the consultation of doctors. The advice was
New Delhi [India]: The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting
Hyderabad (Telangana) [India]: Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be “safe, well-tolerated, and immunogenic” in
New Delhi [India] : The Central government is examining the recommendation of the Subject Expert Committee (SEC) regarding the grant of market authorization of Covaxin
Hyderabad (Telangana) [India]: Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech’s Covaxin.As per phase-three clinical trials
New Delhi [India] ): Bharat Biotech’s US partner Ocugen has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use
Georgetown [Guyana] : Guyana has recognised Bharat Biotech’s Covaxin COVID-19 vaccine, said High Commission of India in Georgetown, Guyana on Tuesday.“#Guyana has recognized #India’s indigenous
Canberra [Australia] : Australian government on Monday gave recognition to Bharat Biotech’s Covaxin COVID-19 vaccine for the purpose of establishing a traveller’s vaccination status in
New Delhi [India] : Union Health Minister Mansukh Mandaviya on Tuesday said that approval for Hyderabad-based Bharat Biotech’s COVID-19 vaccine Covaxin will be given on
New Delhi [India] : After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children
The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech’s submission on emergency use listing (EUL) for its Covaxin COVID-19
Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19
Hyderabad (Telangana) [India]: In order to augment the Covid-19 vaccine production capacity in our country so that a significant percentage of the population can get
Hyderabad (Telangana) [India]: Amid the reports of delayed production of its COVID-19 vaccine due to unsatisfactory test batch and quality issues, Hyderabad-based manufacturer Bharat Biotech
New Delhi [India], August 5 : Bharat Biotech manufactured COVID-19 vaccine Covaxin on Thursday received a certificate of Good Manufacturing Practice (GMP) compliance from the
Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent
New Delhi [India]: Bharat Biotech Managing Director (MD) D Krishna Ella and Joint MD Suchitra Ella received the Padma Bhushan award from President Ram Nath
New Delhi [India]: Experts said that those children who are getting anti-COVID vaccines should not take paracetamol before the consultation of doctors. The advice was
New Delhi [India]: The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting
Hyderabad (Telangana) [India]: Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be “safe, well-tolerated, and immunogenic” in
New Delhi [India] : The Central government is examining the recommendation of the Subject Expert Committee (SEC) regarding the grant of market authorization of Covaxin
Hyderabad (Telangana) [India]: Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech’s Covaxin.As per phase-three clinical trials
New Delhi [India] ): Bharat Biotech’s US partner Ocugen has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use
Georgetown [Guyana] : Guyana has recognised Bharat Biotech’s Covaxin COVID-19 vaccine, said High Commission of India in Georgetown, Guyana on Tuesday.“#Guyana has recognized #India’s indigenous
Canberra [Australia] : Australian government on Monday gave recognition to Bharat Biotech’s Covaxin COVID-19 vaccine for the purpose of establishing a traveller’s vaccination status in
New Delhi [India] : Union Health Minister Mansukh Mandaviya on Tuesday said that approval for Hyderabad-based Bharat Biotech’s COVID-19 vaccine Covaxin will be given on
New Delhi [India] : After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children
The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech’s submission on emergency use listing (EUL) for its Covaxin COVID-19
Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19
Hyderabad (Telangana) [India]: In order to augment the Covid-19 vaccine production capacity in our country so that a significant percentage of the population can get
Hyderabad (Telangana) [India]: Amid the reports of delayed production of its COVID-19 vaccine due to unsatisfactory test batch and quality issues, Hyderabad-based manufacturer Bharat Biotech
New Delhi [India], August 5 : Bharat Biotech manufactured COVID-19 vaccine Covaxin on Thursday received a certificate of Good Manufacturing Practice (GMP) compliance from the
Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent